Directory

>

Ahmed Samatar

avatar

Ahmed Samatar

CEO/CSO & Co-Founder | Zentalis Pharmaceuticals

New York, New York, United States

View contact details (it's free)

Ahmed Samatar

Summary

Ahmed Samatar is a seasoned executive in the biopharmaceutical industry, particularly in drug discovery and clinical development. As a co-founder of Zentalis Pharmaceuticals, he has successfully advanced multiple small molecule inhibitors into clinical trials, showcasing his expertise in oncology and translational medicine. With a strong academic background, including a Ph.D. in Cellular and Developmental Biology, he has built robust networks with both academic institutions and major pharmaceutical companies. His leadership skills are evident in his ability to assemble and guide cross-functional teams toward successful drug development. Recognized as a pioneer in the discovery of MAPK inhibitors, Ahmed continues to contribute to the field through his publications and innovative research. His career highlights include leading the development of the first ERK inhibitor into clinical trials, demonstrating his commitment to advancing cancer therapies.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Ahmed Samatar

Work Experience

💼

CEO/CSO & Co-Founder at

Slap Pharma

September 2021 - Present

company logo

Co-founder & Consultant at

Zentalis Pharmaceuticals

July 2021 - Present

company logo

Co-founder & Senior Vice President-Oncology Research at

Zentalis Pharmaceuticals

December 2014 - July 2021

💼

Founder at

Theramet Biosciences

December 2013 - December 2014

company logo

Team Lead / Director - Oncology Drug Discovery and Development at

Merck

January 2011 - November 2013

company logo

Senior Principal Scientist / Program Lead at

Merck

January 2010 - January 2011

💼

Principal Scientist at

Schering-Plough Research Institute

March 2010 - November 2010

💼

Associate Principal Scientist at

Schering-Plough Research Institute

January 2006 - January 2010

💼

Senior Scientist at

Schering-Plough Research Institute

January 2002 - January 2006

💼

Post doctoral fellow at

Schering-Plough Research Institute

January 1999 - January 2002

💼

Graduate Student at

Cold Spring Harbor Laboratory Association, Inc.

July 1993 - August 1999

Logos provided by Logo.dev

Ahmed Samatar

Education

Cold Spring Harbor Laboratory, Doctor Of Philosophy (Ph.D.)

January 1993 - January 1999

Stony Brook University, Doctor Of Philosophy (Ph.D.)

January 1993 - January 1999

Friends World College / Long Island University, Bachelor Of Arts (Ba)

January 1988 - January 1992

Frequently Asked Questions about Ahmed Samatar

What is Ahmed Samatar email address?

Ahmed Samatar's primary email address is ********@zentalis.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Ahmed Samatar work for?

Ahmed Samatar is a CEO/CSO & Co-Founder at Zentalis Pharmaceuticals, a company specializing in Commercial physical research.

Where Ahmed Samatar graduated from?

Ahmed Samatar holds a degree in Cellular And Developmental Biology from Cold Spring Harbor Laboratory.

How can I directly contact Ahmed Samatar?

To contact Ahmed Samatar directly, you can use the email address ********@zentalis.com. Complete contact information is available upon registration with Muraena.

Who is Ahmed Samatar?

Ahmed Samatar is a seasoned executive in the biopharmaceutical industry, particularly in drug discovery and clinical development. As a co-founder of Zentalis Pharmaceuticals, he has successfully advanced multiple small molecule inhibitors into clinical trials, showcasing his expertise in oncology and translational medicine. With a strong academic background, including a Ph.D. in Cellular and Developmental Biology, he has built robust networks with both academic institutions and major pharmaceutical companies. His leadership skills are evident in his ability to assemble and guide cross-functional teams toward successful drug development. Recognized as a pioneer in the discovery of MAPK inhibitors, Ahmed continues to contribute to the field through his publications and innovative research. His career highlights include leading the development of the first ERK inhibitor into clinical trials, demonstrating his commitment to advancing cancer therapies.

Ahmed`s contact details

mail

********@zentalis.com

Colleagues

avatar
Nicolas Pelletier

Vice President, Quality

avatar
Olivier Harismendy

Vice President, Translational Data Science and Computational Biology

avatar
Stephan Grant

Vice President, Discovery Biology

avatar
Alexis Pinto

Advisory Board Member

avatar
Geraldine Peters-Wiles Ms Sphr

VP of Human Resources

avatar
Grace Vandal

Executive Director, Alliance and Program Management

avatar
Bob Divasto

Senior Vice President Technical Operations and Head of CMC

avatar
Matthew Peterson

Executive Director Chemical Development

Monica Reckner

Vice President of Clinical Sciences

avatar
Crystal Spivey

Executive Business Partner - Office of the CFO and CSO

View Contact details (it's free)
Request Profile Removal